BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer.

Saved in:
Bibliographic Details
Title: BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer.
Authors: Francies FZ; iThemba LABS-National Research Foundation, Somerset West, South Africa. flavia.zita4@gmail.com.; Department of Radiation Sciences, University of the Witwatersrand, Johannesburg, South Africa. flavia.zita4@gmail.com., Wainstein T; Division of Human Genetics, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa. Tasha.Wainstein@nhls.ac.za., De Leeneer K; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium. Kim.Deleeneer@ugent.be., Cairns A; Department of Surgery, Charlotte Maxeke Johannesburg Academic Hospital and Donald Gordon Medical Centre, Johannesburg, South Africa. acairns@tiscali.co.za., Murdoch M; Department of Surgery, Charlotte Maxeke Johannesburg Academic Hospital and Donald Gordon Medical Centre, Johannesburg, South Africa. marshall.murdoch@gmail.com., Nietz S; Department of Surgery, Charlotte Maxeke Johannesburg Academic Hospital and Donald Gordon Medical Centre, Johannesburg, South Africa. sarah.nietz@gmx.de., Cubasch H; Batho Pele Breast Unit, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa. hcubasch@worldonline.co.za., Poppe B; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium. Bruce.Poppe@ugent.be., Van Maerken T; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium. Tom.Vanmaerken@ugent.be., Crombez B; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium. Brecht.Crombez@ugent.be., Coene I; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium. Ilse.Coene@ugent.be., Kerr R; Division of Human Genetics, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa. Robyn.Kerr@nhls.ac.za., Slabbert JP; iThemba LABS-National Research Foundation, Somerset West, South Africa. jps@tlabs.ac.za., Vral A; Department of Basic Medical Sciences, Ghent University, Ghent, Belgium. Anne.vral@ugent.be., Krause A; Division of Human Genetics, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa. Amanda.Krause@nhls.ac.za.; Division of Human Genetics, National Health Laboratory Services, Johannesburg, South Africa. Amanda.Krause@nhls.ac.za., Baeyens A; iThemba LABS-National Research Foundation, Somerset West, South Africa. Ans.Baeyens@wits.ac.za.; Department of Radiation Sciences, University of the Witwatersrand, Johannesburg, South Africa. Ans.Baeyens@wits.ac.za.; Department of Basic Medical Sciences, Ghent University, Ghent, Belgium. Ans.Baeyens@wits.ac.za., Claes KB; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium. Kathleen.Claes@ugent.be.
Source: BMC cancer [BMC Cancer] 2015 Nov 17; Vol. 15, pp. 912. Date of Electronic Publication: 2015 Nov 17.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first